Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126544) titled 'Clinical study on the efficacy and safety of Peginterferon alfa-2b injection combined with TKI in the treatment of patients with chronic-phase chronic myeloid leukemia' on June 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Second Medical Center of Chinese PLA General Hospital
Condition:
Chronic-phase chronic myeloid leukemia
Intervention:
The PEG-IFNa-2b combined with TKI group(Cohort 1 ):None
TKI group(Cohort 1):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-12
Target Sample Size: The PEG-IFNa-2b combined with TKI group(Coh...